| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Stalfort John A III is a Director at Verrica Pharmaceuticals Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 9 buys and 0 sells.
Estimated insider holdings value: $23.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 22, 2024 | VRCA Verrica Pharmaceuticals Inc. | Director | Buy | 1,123,595 | $0.00 | - | +160.5% | -25.4% | -57.7% | |
| Aug 16, 2023 | TSHA Taysha Gene Therapies, Inc. | Director | Buy | 777,778 | $0.90 | $700,000.20 | +70.3% | -31.1% | +18.7% | |
| Jul 5, 2022 | VRCA Verrica Pharmaceuticals Inc. | Director | Buy | 238,095 | $2.10 | $499,999.50 | +51.5% | +19.6% | +136.8% | |
| Jul 6, 2021 | ABOS Acumen Pharmaceuticals, Inc. | Director | Buy | 35,000 | $16.00 | $560,000.00 | +25.5% | -25.0% | -72.8% | |
| Aug 14, 2020 | VRCA Verrica Pharmaceuticals Inc. | Director | Buy | 31,250 | $6.41 | $200,463.50 | +3.6% | - | - | |
| Jan 7, 2019 | VRCA Verrica Pharmaceuticals Inc. | Director | Buy | 9,221 | $10.45 | $96,385.98 | +1.1% | - | - |